
PMC:7318948 / 17582-18503
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T251 | 108-116 | SP_7 | denotes | COVID-19 |
T252 | 154-159 | UBERON:0000062 | denotes | organ |
T253 | 184-188 | PR:000001393 | denotes | IL-6 |
T254 | 189-198 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T255 | 298-309 | DG_35 | denotes | tocilizumab |
T256 | 386-397 | UBERON:0001004 | denotes | respiratory |
T257 | 563-574 | UBERON:0001004 | denotes | respiratory |
T258 | 600-614 | GO:0007596 | denotes | Thromboembolic |
T259 | 655-666 | UBERON:0001004 | denotes | respiratory |
T260 | 771-779 | SP_7 | denotes | COVID-19 |
T261 | 800-805 | UBERON:0000062 | denotes | organ |
T262 | 889-897 | SP_7 | denotes | COVID-19 |
T53081 | 108-116 | SP_7 | denotes | COVID-19 |
T40237 | 154-159 | UBERON:0000062 | denotes | organ |
T50732 | 184-188 | PR:000001393 | denotes | IL-6 |
T20616 | 189-198 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T9065 | 298-309 | DG_35 | denotes | tocilizumab |
T92411 | 386-397 | UBERON:0001004 | denotes | respiratory |
T9846 | 563-574 | UBERON:0001004 | denotes | respiratory |
T4781 | 600-614 | GO:0007596 | denotes | Thromboembolic |
T63580 | 655-666 | UBERON:0001004 | denotes | respiratory |
T70599 | 771-779 | SP_7 | denotes | COVID-19 |
T64011 | 800-805 | UBERON:0000062 | denotes | organ |
T48557 | 889-897 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T94 | 148-159 | Body_part | denotes | solid organ | http://purl.org/sig/ont/fma/fma55670 |
T95 | 411-419 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T96 | 794-805 | Body_part | denotes | solid organ | http://purl.org/sig/ont/fma/fma55670 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T52 | 154-159 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062 |
T53 | 800-805 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T88 | 108-116 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T89 | 386-405 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
T90 | 655-674 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
T91 | 771-779 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T92 | 889-897 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T220 | 154-159 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organ |
T221 | 317-318 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T222 | 442-443 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T223 | 525-526 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T224 | 645-646 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T225 | 676-677 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T226 | 800-805 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organ |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T185 | 184-186 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T187 | 189-198 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T188 | 298-309 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
434 | 184-188 | Gene | denotes | IL-6 | Gene:3569 |
435 | 117-125 | Species | denotes | patients | Tax:9606 |
436 | 206-213 | Species | denotes | patient | Tax:9606 |
437 | 350-357 | Species | denotes | patient | Tax:9606 |
438 | 464-472 | Species | denotes | patients | Tax:9606 |
439 | 780-788 | Species | denotes | patients | Tax:9606 |
440 | 298-309 | Chemical | denotes | tocilizumab | MESH:C502936 |
441 | 108-116 | Disease | denotes | COVID-19 | MESH:C000657245 |
442 | 386-405 | Disease | denotes | respiratory failure | MESH:D012131 |
443 | 563-583 | Disease | denotes | respiratory distress | MESH:D012128 |
444 | 600-624 | Disease | denotes | Thromboembolic phenomena | MESH:D013923 |
445 | 655-674 | Disease | denotes | respiratory failure | MESH:D012131 |
446 | 771-779 | Disease | denotes | COVID-19 | MESH:C000657245 |
447 | 889-897 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T37 | 386-405 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
T38 | 411-425 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
T39 | 563-583 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T40 | 600-614 | Phenotype | denotes | Thromboembolic | http://purl.obolibrary.org/obo/HP_0001907 |
T41 | 655-674 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T156 | 0-172 | Sentence | denotes | In conclusion, there is limited data on the clinical presentation, management, and appropriate treatment of COVID-19 patients who are recipients of solid organ transplants. |
T157 | 173-406 | Sentence | denotes | The use of IL-6 inhibitor in our patient resulted in clinical improvement initially, but it is difficult to determine if the tocilizumab played a role in the management of this patient, specifically in preventing respiratory failure. |
T158 | 407-599 | Sentence | denotes | The cytokine storm appears to play a major role in these patients, and it is possible that several of them experience a second storm that results in severe respiratory distress and intubation. |
T159 | 600-675 | Sentence | denotes | Thromboembolic phenomena also appear to play a role in respiratory failure. |
T160 | 676-818 | Sentence | denotes | A single case does not represent the complex strategy needed when considering the treatment of COVID-19 patients with solid organ transplants. |
T161 | 819-921 | Sentence | denotes | Further studies are necessary to investigate treatment modalities for COVID-19 in special populations. |